June 5 to June 8, 2004
Pressemeldung: | |
|---|---|
Tagung der Amerikanischen Gesellschaft für Klinische Onkologie (ASCO): |
|
Pressemeldung: | |
|---|---|
Neue Entwicklungssubstanz von Bayer HealthCare zur Krebsbehandlung |
|
BAY 43-9006 Fact Sheet (englisch): |
|
BAY 43-9006 Clinical Trial Overview (englisch): |
|
Background Information on Renal Cell Cancer (englisch): |
|
Background Information on Melanoma (englisch): |
|
List of BAY 43-9006 Presentations at ASCO 2004 (englisch): |
|
Preliminary antitumor activity of BAY 43-9006 in metastatic renal cell carcinoma and other advanced refractory solid tumors in a phase II randomized discontinuation trial: Abstract No: 4501
Phase I/II trial of BAY 43-9006, carboplatin and paclitaxel demonstrates preliminary antitumor activity in the expansion cohort of patients with metastatic melanoma: Abstract No: 7507
A randomized phase I clinical and biologic study of two schedules of BAY 43-9006 in patients with myelodysplastic syndrome or acute myeloid leukemia: A National Cancer Institute of Cancer Clinical Trials Group Study: Abstract No: 6611
A phase I/II trial of BAY 43-9006 and gemcitabine in advanced solid tumors and in advanced pancreatic cancer: Abstract No: 3059
Results of a phase I trial of BAY 43-9006 in combination with doxorubicin in patients with refractory solid tumors: Abstract No: 3049
Novel methodology of response assessment in hepatocellular carcinoma – Assessing response by change in tumor enhancement in distinction from conventional means: Abstract No: 3107
Results of a phase I trial of BAY 43-9006 in combination with oxaliplatin in patients with refractory solid tumors: Abstract No: 3056
Pharmacodynamic study of the raf kinase inhibitor BAY 43-9006: Mechanisms of hypertension: Abstract No: 2035
BAY 43-9006 in patients with advanced melanoma: The Royal Marsden experience: Abstract No: 7506
Glossary of Terms (englisch): |
|
ASCO Homepage: www.asco.org
Clinical trials information: www.clinicaltrials.gov
American Cancer Society: www.cancer.org
Information on renal cell cancer: www.kidneycancerassociation.org
Information on melanoma: www.melanomainternational.org
Sie verlassen die Website der Bayer AG.
Die Bayer AG ist für den Inhalt der nachfolgenden Website nicht verantwortlich.
sammeln